Financial toxicity describes the financial burden and distress that can arise for patients, and
their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for …

Simple Summary In oncology, treatment outcomes can be competing, which means that one
treatment could benefit one outcome, like survival, and negatively influence another, like …

Importance Financial toxicity (FT) is the negative impact of cost of care on financial well-
being. Patients with breast cancer are at risk for incurring high out-of-pocket costs given the …

Background Shared decision‐making (SDM) occurs when a patient partners with their
oncologist to integrate personal preferences and values into treatment decisions. A key …

Objectives This study sought to explore the use of novel natural language processing (NLP)
methods for classifying unstructured, qualitative textual data from interviews of patients with …

Introduction Treatment advances for metastatic breast cancer (mBC) have improved overall
survival (OS) in some mBC subtypes; however, there remains no cure for mBC. Considering …

Objectives Proponents of shared decision-making (SDM) advocate the elicitation of the
patient's perspective. This scoping review explores if, and to what extent, the personal …

Americans will be diagnosed with cancer at some point of their lifetimes (Brenner et al.,
2020). With improved screening, detection and treatments, the number of survivors is …

Background Burdens related to time spent receiving cancer care may be substantial for
patients with incurable, life‐limiting cancers such as metastatic breast cancer (MBC) …

Background Quality of life (QOL) is a critical factor in decision-making for advanced breast
cancer (ABC). There is a need to improve how QOL and treatment-related side effects (SEs) …